Elevated fasting blood glucose at admission is associated with poor outcomes in patients with COVID-19
- PMID: 32896652
- PMCID: PMC7472974
- DOI: 10.1016/j.diabet.2020.08.004
Elevated fasting blood glucose at admission is associated with poor outcomes in patients with COVID-19
Comment on
-
Patients with diabetes are at higher risk for severe illness from COVID-19.Diabetes Metab. 2020 Sep;46(4):335-337. doi: 10.1016/j.diabet.2020.05.001. Epub 2020 May 13. Diabetes Metab. 2020. PMID: 32416321 Free PMC article.
References
-
- Wang S., Ma P., Zhang S., Song S., Wang Z., Ma Y. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia. 2020 doi: 10.1007/s00125-020-05209-1. [Online ahead of print] - DOI - PMC - PubMed
-
- WHO . 2020. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. Available from www.who.int/publications-detail/laboratory-testing-for-2019-novel-corona.... Accessed 18 July 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
